Side-Effect Management

Lower Dose Olanzapine Plus Triplet Antiemetic Therapy May Reduce Chemotherapy-Induced Nausea and Vomiting

By

Susan Moench, PhD, PA-C

Olanzapine added to triplet antiemetic therapy, has been shown to reduce risk of chemotherapy-induced nausea and vomiting, but can cause daytime sleepiness.

Enteral Nutrition Versus Parenteral Nutrition in Patients With Cancer

By

Vicki Moore, PhD

Parenteral nutrition showed a higher rate of infection than enteral nutrition, according to results of a recent updated literature review and meta-analysis.

The Benefits of Yoga for Cancer Patients

By

Marlee Kiel, LMSW CancerCare

A review of the ways that a yoga practice can help patients cope with their cancer and manage the physical symptoms and side effects of treatment.

Survey Reveals Perspective on Use of Support Garments Varies Among Patients With a Urostomy

By

Vicki Moore, PhD

Patients’ survey responses ranged from the garments cause discomfort to they alleviate discomfort. Some responses indicated patients face a possible trade-off between comfort and protection in finding the optimal support garment.

Emerging Clinical Tool Predicts Risk of Persistent Use of Opioids After Treatment in Patients With Cancer

By

Bette Weinstein Kaplan

Investigators at UCSD sought to create a tool to help clinicians predict patients’ risk of persistent opioid use after treatment.

Phase 2 Trial of Ibrutinib, Bortezomib, Dexamethasone Combination for R/R Multiple Myeloma Was Closed Early

By

Susan Moench, PhD, PA-C

Despite an overall response rate of 57%, this clinical trial was suspended due to safety concerns then closed early due to insufficient activity of the study drug combination.

Adverse Events Decreased With Proton Chemoradiotherapy

Relative risks lower for 90-day adverse events of at least grade 3 and 2 compared with photon therapy.

Permanent Chemotherapy-Induced Alopecia: Study Reveals Knowledge and Practice Gaps Occur Across Multiple Disciplines

By

Susan Moench, PhD, PA-C

A survey found that dermatologists have more confidence in diagnosing, managing, and their personal knowledge of permanent chemotherapy-induced alopecia compared with clinicians who practice in oncology or primary care/internal medicine.

Antibiotic Prophylaxis Shown to Reduce Infection Risk for Patients With Newly Diagnosed Multiple Myeloma

By

Vicki Moore, PhD

Prophylactic antibiotics trended toward reducing infection risk at 3 months if given in first 2 to 3 months after MM diagnosis; however, it had no effect on mortality rates.

Acupuncture, Acupressure May Help Cancer Patients Control Pain

Review also shows link between acupuncture or acupressure and reduction in analgesic use.